None listed
Conditions
Brief summary
Peripheral intravenous catheters (PIVCs) are catheters that are inserted into peripheral veins to give medical treatment such as medicines, fluids, and blood transfusions. PIVCs are the most frequently used vascular access device in Australia. This is largely due to the current workforce model in which most PIVC inserters are doctors and nurses (generalist) inserting PIVCs within their existing roles. There are, however, alternate intravenous (IV) devices available which a specialist in Vascular Access has the specialised knowledge and skills available to insert. Our research project aims to find out whether the standard practice of a PIVC device being inserted by your bedside nurse or doctor affects how long the IV device functions and patient satisfaction. Hypothesis 1: The hypothesis for the feasibility of this study is that we will be able to recruit the required number of patients and they will remain within the study for the duration of data collection. The study will adhere to the processes outlined in the study protocol, and data will be collected and complete. Hypothesis 2: The hypothesis for the clinical outcome of the study is that the Vascular Access Specialist will be more successful than usual care in peripheral intravenous catheter insertion with lower incidence of failure and complications and less pain to the patient.
Interventions
Intervention
A Vascular Access Specialist [VAS] can be defined as a clinician with advanced knowledge in vascular access insertion. This includes device selection; device management in terms of treatment duration and medication administration guidelines, and the use of ultrasound guidance for device placement.
Through evaluation of the patients medical notes/treatment plan, and direct assessment of the patient, the VAS will determine the best device choice. This assessment should take between
Intervention A Vascular Access Specialist [VAS] can be defined as a clinician with advanced knowledge in vascular access insertion. This includes device selection; device management in terms of treatment duration and medication administration guidelines, and the use of ultrasound guidance for device placement. Through evaluation of the patients medical notes/treatment plan, and direct assessment of the patient, the VAS will determine the best device choice. This assessment should take between 10-20 minutes. The VAS will assess ALL potential participants referred to the study prior to randomisation. At this time the VAS will determine the most appropriate device for the participants needs and this decision will be recorded within clinical trial data files and remain confidential. The participant will then be randomised. If randomised to intervention, device selection and insertion will be carried out by the VAS and the peripheral intravenous device (per VAS assessment; with/without ultrasound guidance) will be inserted. PIVC device insertion by the VAS will take no longer than device insertion performed as per standard care (no more than 15 minutes). Post insertion, the PIVC device care will be undertaken as per standard hospital policy. In addition to standard care, the Research Nurse will review both intervention and control participants PIVC sites daily (5 minutes duration) until 48 hours post device removal. The Research Nurse will also access clinical notes for information relating to PIVC management (i.e. ongoing treatment plan/ complications/ need for device replacement etc). This will take 5-10 minutes daily. Adherence to the intervention will be assessed under feasibility outcomes.
Sponsors
The Prince Charles Foundation - Common Good Grant
Study design
Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Prevention
Masking
Blinded (masking used) (Investigator, Outcomes Assessor)
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
Inclusion criteria • Greater than or equal to 18 years of age • Requiring peripherally compatible intravenous therapy for greater than 24 hours • Informed written consent
Exclusion criteria
Exclusion criteria • Greater than or equal to 18 years of age • Receiving end-of-life care • Limited English/ without interpreter • Inability to consent for self (i.e. cognitive impairment) • Previous study enrolment
Outcome results
None listed